InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-31.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Mallick Parag, Executive. Director active across 1 company, notably Nautilus Biotechnology, Inc.. In total, 2 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €8k. History available since 21 December 2021. The latest transaction was disclosed on 8 May 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Mallick Parag
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
12,000 shares@ US$0.7323100.0% of flowCommon StockSEC:0001808805-25-000049:0
Canonical exit: 6 Aug 2025 (T+90)
210,000 shares0Common StockSEC:0001808805-21-000031:0
2 of 2 declarations
About Mallick Parag
Mallick Parag holds an Executive position at Nautilus Biotechnology, Inc. In this role, he contributes to the strategic management of the company and the optimization of operations. His expertise in the biotechnology sector is an asset in achieving growth objectives and enhancing the customer experience. Mallick Parag plays a key role in developing the company's initiatives.
